Sinaceph is indicated for the following diseases: Skin and Soft tissue infection: Abscess, cellulitis, furunculosis, impetigo Urinary tract infection: Cystitis, urethritis, pyelonephritis. Upper and lower respiratory tract infection: Pharyngitis, sinusitis, otitis media, tonsilitis acute and chronic bronchitis, lobar and bronchopneumonia; Gastrointestinal infection: Bacillary dysentry, enteritis, peritonitis. Genital Infection; Bones and joint infection; Nose, ear and throat infection; post operative infection and Infections caused by sensitive microorganism of Cephradine.
Sinaceph 250 Capsule: Each capsule contains Cephradine BP 250 mg. Sinaceph 500 Capsule: Each capsule contains Cephradine BP 500 mg. Sinaceph Suspension: Alter reconstitution each 5 ml suspension contains Cephradine BP 125 mg. Sinaceph DS Suspension: After reconstitution each 5 ml suspension contains Cephradine BP 250 mg. Sinaceph Paediatric Drops: After reconstitution each mi suspension contains Cephradine AP mg. Sinaceph 500 Injection: Each vial contains Cephradine BP 500 mg. Sinaceph 1gm Injection: Each vial contains Cephradine BP 1 gm
Cephradine is contraindicated to patients who are hypersensitive to cephalosporin group of antibiotics.
Give cautiously to penicillin sensitive patients as there is evidence of partial cross-allergenicity between the Cephalosporin and patients with ma arkedly impaired renal function. Cephalosporin is excreted in breast milk and should be given with caution in lactating mothers.
Nausea, vomiting, diarrhoea and abdominal discomfort may occur. Besides this the count of eosinophil and neutrophil may be increased and decreased respectively for some patients.